$HUN

Huntsman CORP

No enriched coverage for $HUN in the last 7 days.

No SEC Form 4 filings for $HUN in the last 30 days.

Med

Huntsman Corp. Opens Weak with Gap Down Amid Market Concerns

Huntsman Corp., a small-cap chemicals company, opened with a significant 5.73% decline, part of a broader 14.74% drop over the past day and a 22.37% fall over the last month. The company, with a market capitalization of USD 2.55 billion, is currently operating at a loss, as indicated by its negative return on equity and mixed technical indicators. Despite a high dividend yield, its financial performance and stock market trend suggest bearish sentiment.

Huntsman Corp stock faces 'Reduce' rating amid chemicals sector pressures and dividend payout

Huntsman Corp (NYSE: HUN) has received a 'Reduce' consensus rating from analysts due to weak Q4 2025 earnings and broader chemicals industry headwinds. Despite low valuations and a dividend yield exceeding 7%, the company faces margin pressures and soft global demand. The article highlights both the risks for DACH investors, including industrial slowdowns, and the potential attraction of its high dividend yield for income-focused portfolios.

Huntsman Corp stock (ISIN: US4470111075) faces earnings headwinds as short interest rises

Huntsman Corporation (NYSE: HUN) is experiencing significant operational challenges, including reported losses and missed revenue targets, leading to increased short-seller activity. The company's pivot to higher-margin specialty products has stalled, raising concerns about dividend sustainability and future profitability. Analysts predict further losses, and the rising short interest ahead of dividend payments suggests market skepticism about a prompt recovery.

News on $HUN